Tulloh RM - Search Results

1

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease.

Feltes TF, Sondheimer HM, Tulloh RM, Harris BS, Jensen KM, Losonsky GA, Griffin MP; Motavizumab Cardiac Study Group. Feltes TF, et al. Among authors: tulloh rm. Pediatr Res. 2011 Aug;70(2):186-91. doi: 10.1203/PDR.0b013e318220a553. Pediatr Res. 2011. PMID: 21522037 Clinical Trial.

2

The European Forum for Clinical Management: prophylaxis against the respiratory syncytial virus in infants and young children with congenital cardiac disease.

Tulloh RM, Feltes TF. Tulloh RM, et al. Cardiol Young. 2005 Jun;15(3):274-8. doi: 10.1017/S1047951105000569. Cardiol Young. 2005. PMID: 15865829 Review.

3

Prevention and prophylaxis of respiratory syncytial virus in pediatric cardiology: a UK perspective.

Tulloh RM, Bury S. Tulloh RM, et al. Future Cardiol. 2014 Mar;10(2):235-42. doi: 10.2217/fca.14.4. Future Cardiol. 2014. PMID: 24762251 Review.

4

Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.

Tulloh R, Marsh M, Blackburn M, Casey F, Lenney W, Weller P, Keeton BR; Working Group of the British Paediatric Cardiac Association. Tulloh R, et al. Cardiol Young. 2003 Oct;13(5):420-3. Cardiol Young. 2003. PMID: 14694935

5

CHD and respiratory syncytial virus: global expert exchange recommendations.

Tulloh RMR, Medrano-Lopez C, Checchia PA, Stapper C, Sumitomo N, Gorenflo M, Jung Bae E, Juanico A, Gil-Jaurena JM, Wu MH, Farha T, Dodge-Khatami A, Tsang R, Notario G, Wegzyn C. Tulloh RMR, et al. Cardiol Young. 2017 Oct;27(8):1504-1521. doi: 10.1017/S1047951117000609. Epub 2017 Jun 16. Cardiol Young. 2017. PMID: 28619123

6

Pulmonary hypertension in congenital heart disease.

Pascall E, Tulloh RM. Pascall E, et al. Among authors: tulloh rm. Future Cardiol. 2018 Jul;14(4):343-353. doi: 10.2217/fca-2017-0065. Epub 2018 May 24. Future Cardiol. 2018. PMID: 29792339 Free PMC article. Review.

7

Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension.

Sallmon H, Moledina S, Albert DC, Beghetti M, Berger RMF, Bonnet D, Bukova M, Koestenberger M, Meinel K, Reinhardt Z, Tulloh RMR, de Wolf D, Hansmann G. Sallmon H, et al. Among authors: tulloh rmr. Cardiol Young. 2019 Nov;29(11):1323-1327. doi: 10.1017/S104795111900235X. Epub 2019 Sep 26. Cardiol Young. 2019. PMID: 31554525 Review.

8

Patent ductus arteriosus: an analysis of management.

Wardle AJ, Osman A, Tulloh R, Luyt K. Wardle AJ, et al. Cardiol Young. 2014 Oct;24(5):941-3. doi: 10.1017/S1047951113001583. Epub 2013 Oct 24. Cardiol Young. 2014. PMID: 24153161

9

Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension.

Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ. Skinner GJ, et al. Among authors: tulloh rm. Cardiol Young. 2013 Oct;23(5):692-6. doi: 10.1017/S1047951112001771. Epub 2012 Oct 23. Cardiol Young. 2013. PMID: 23089055

10

Comparison of the effect of inhaled anaesthetic with intravenous anaesthetic on pulmonary vascular resistance measurement during cardiac catheterisation.

Giesen LA, White M, Tulloh RM. Giesen LA, et al. Among authors: tulloh rm. Cardiol Young. 2015 Feb;25(2):368-72. doi: 10.1017/S1047951114000195. Epub 2014 Feb 19. Cardiol Young. 2015. PMID: 24548796 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters